229 related articles for article (PubMed ID: 15978535)
1. Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis.
Dodd JD; Barry SC; Daly LE; Gallagher CG
J Cyst Fibros; 2005 May; 4(2):101-5. PubMed ID: 15978535
[TBL] [Abstract][Full Text] [Related]
2. Respiratory factors do not limit maximal symptom-limited exercise in patients with mild cystic fibrosis lung disease.
Dodd JD; Barry SC; Gallagher CG
Respir Physiol Neurobiol; 2006 Jun; 152(2):176-85. PubMed ID: 16169290
[TBL] [Abstract][Full Text] [Related]
3. Effects of acute salbutamol inhalation on quadriceps force and fatigability.
Decorte N; Verges S; Flore P; Guinot M; Wuyam B
Med Sci Sports Exerc; 2008 Jul; 40(7):1220-7. PubMed ID: 18580400
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.
Jensen D; Amjadi K; Harris-McAllister V; Webb KA; O'Donnell DE
Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181
[TBL] [Abstract][Full Text] [Related]
5. Effect of albuterol on maximal exercise capacity in cystic fibrosis.
Serisier DJ; Coates AD; Bowler SD
Chest; 2007 Apr; 131(4):1181-7. PubMed ID: 17426226
[TBL] [Abstract][Full Text] [Related]
6. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction.
Inman MD; O'Byrne PM
Am J Respir Crit Care Med; 1996 Jan; 153(1):65-9. PubMed ID: 8542164
[TBL] [Abstract][Full Text] [Related]
7. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis.
Schnabel D; Grasemann C; Staab D; Wollmann H; Ratjen F;
Pediatrics; 2007 Jun; 119(6):e1230-8. PubMed ID: 17545356
[TBL] [Abstract][Full Text] [Related]
8. Inhaled salbutamol and endurance cycling performance in non-asthmatic athletes.
van Baak MA; de Hon OM; Hartgens F; Kuipers H
Int J Sports Med; 2004 Oct; 25(7):533-8. PubMed ID: 15459835
[TBL] [Abstract][Full Text] [Related]
9. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests.
Porto EF; Castro AA; Nascimento O; Oliveira RC; Cardoso F; Jardim JR
Respir Med; 2009 Feb; 103(2):251-7. PubMed ID: 18930646
[TBL] [Abstract][Full Text] [Related]
10. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis.
Fitzgerald DA; Hilton J; Jepson B; Smith L
Pediatrics; 2005 Oct; 116(4):e549-54. PubMed ID: 16147970
[TBL] [Abstract][Full Text] [Related]
11. The effect of salbutamol on performance in elite nonasthmatic athletes.
Meeuwisse WH; McKenzie DC; Hopkins SR; Road JD
Med Sci Sports Exerc; 1992 Oct; 24(10):1161-6. PubMed ID: 1435165
[TBL] [Abstract][Full Text] [Related]
12. Effect of low altitude at the Dead Sea on exercise capacity and cardiopulmonary response to exercise in cystic fibrosis patients with moderate to severe lung disease.
Falk B; Nini A; Zigel L; Yahav Y; Aviram M; Rivlin J; Bentur L; Avital A; Dotan R; Blau H
Pediatr Pulmonol; 2006 Mar; 41(3):234-41. PubMed ID: 16429430
[TBL] [Abstract][Full Text] [Related]
13. Effect of DNase on exercise capacity in cystic fibrosis.
Barker M; Franke E; Böhle M; Pfannenstiel C; Heimann G
Pediatr Pulmonol; 2004 Jul; 38(1):70-4. PubMed ID: 15170876
[TBL] [Abstract][Full Text] [Related]
14. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study.
Jantikar A; Brashier B; Maganji M; Raghupathy A; Mahadik P; Gokhale P; Gogtay J; Salvi S
Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051
[TBL] [Abstract][Full Text] [Related]
15. High-Dose Inhaled Salbutamol Does Not Improve 10-km Cycling Time Trial Performance.
Koch S; Ahn JR; Koehle MS
Med Sci Sports Exerc; 2015 Nov; 47(11):2373-9. PubMed ID: 25856682
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
17. Timing and driving components of the breathing strategy in children with cystic fibrosis during exercise.
Keochkerian D; Chlif M; Delanaud S; Gauthier R; Maingourd Y; Ahmaidi S
Pediatr Pulmonol; 2005 Nov; 40(5):449-56. PubMed ID: 16163725
[TBL] [Abstract][Full Text] [Related]
18. Does single dose salmeterol affect exercise capacity in asthmatic men?
Robertson W; Simkins J; O'Hickey SP; Freeman S; Cayton RM
Eur Respir J; 1994 Nov; 7(11):1978-84. PubMed ID: 7875268
[TBL] [Abstract][Full Text] [Related]
19. Six-minute walking test in cystic fibrosis adults with mild to moderate lung disease: comparison to healthy subjects.
Chetta A; Pisi G; Zanini A; Foresi A; Grzincich GL; Aiello M; Battistini A; Olivieri D
Respir Med; 2001 Dec; 95(12):986-91. PubMed ID: 11778797
[TBL] [Abstract][Full Text] [Related]
20. Effects of acute inhalation of albuterol on submaximal and maximal VO2 and blood lactate.
Fleck SJ; Lucia A; Storms WW; Wallach JM; Vint PF; Zimmerman SD
Int J Sports Med; 1993 Jul; 14(5):239-43. PubMed ID: 8365829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
